On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayJan 27, 2023 9:45 am

As 50+ Countries Commit to Net-Zero by 2050, GeoSolar Technologies Inc. Helps Facilitate Green Transition with SmartGreen(TM) Home Energy Systems

Every country in the world signed the Paris agreement at COP 21 in 2015, 50+ countries have committed to Net-Zero by 2050 GeoSolar helps ease energy transition with the SmartGreen(TM) whole-home renewable energy system GeoSolar’s SmartGreen(TM) system offers a total-home makeover, including geothermal-powered heat pump, solar panels, upgrades to insulation, windows, lighting systems Every country in the world signed the Paris agreement at COP 21 in 2015 with the shared aim of limiting global temperature increases as close as possible to 1.5 degrees Celsius (https://nnw.fm/dpFmr). Since then, over 50 countries have committed to adopting a net-zero emissions goal by 2050…

Continue Reading

FridayJan 27, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Anticipating ‘Best Year Ever’ in 2023

Lexaria Bioscience recently released its 2023 annual letter from CEO Chris Bunka, providing a strategic update to all stakeholders The letter highlights the key milestones achieved in calendar 2022, outlines expectations for calendar 2023, and indicates why Chris Bunka expects 2023 to be the company’s best year so far 1In calendar 2023, Lexaria expects to attain FDA registration for an investigational new drug (“IND”) program and commence Phase 1(b) clinical study evaluating the safety and tolerability of DehydraTECH(TM)-processed CBD as a treatment for hypertension The company will also be pursuing commercial relationships in 2023 even as its R&D continues to…

Continue Reading

ThursdayJan 26, 2023 10:30 am

Aircraft Designer CubCrafters Inc. Expands Investment Options

Backcountry aviation innovator CubCrafters is advancing its ability to respond to customers of its popular XCub and other aircraft products by welcoming outside investors CubCrafters’ public investment offering was initially introduced last year through a Reg A+ filing qualified by the FTC in November, at which point more than $26 million of its $50 million goal had already been reserved pre-offering The company announced Jan. 17 that it has expanded that investment opportunity to residents in Florida, New Jersey, Texas, and Washington, through a Regulation CF campaign serving non-accredited investors who couldn’t qualify under the Reg A+ program Both investment…

Continue Reading

ThursdayJan 26, 2023 9:45 am

MetAlert, Inc. (MLRT) Planned Acquisition of TrakTec LLC Adds Superior Radio Frequency-Based Tracking Technology to Portfolio of Location-Based Solutions

MetAlert recently announced the planned acquisition of TrakTec LLC, a Florida-based leader in location awareness technology for consumer and business applications The acquisition is expected to add several products to MetAlert’s existing suite of products, one of which is an RFID and Bluetooth-enabled tracking technology called SafetyNet(R) The SafetyNet Tracking System comprises the SafetyNet Bracelets that patients wear, and a receiver-antenna combo used by police departments and first responders The Chelmsford Police Department in Massachusetts recently reported it had successfully located a missing senior citizen with dementia because of its participation in the SafetyNet program The department has, over time,…

Continue Reading

ThursdayJan 26, 2023 9:00 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial

SILO recently provided status update on its sponsored clinical trial with UCSF examining psilocybin’s effects on inflammation Targeted patient populations from study may provide support for development and use of psilocybin as a therapeutic to treat inflammatory conditions Data collection from all study groups expected by April 2023 SILO additionally evaluating its ketamine formulation through its partnership agreement with Zylö Therapeutics Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on…

Continue Reading

WednesdayJan 25, 2023 10:30 am

SideChannel Inc. (SDCH) to Provide Key Operational Updates and Strategic Priorities During Investor Day Virtual Event on February 15, 2023

The February 15, 2023 Investor Day virtual event will be hosted by the company’s President and CEO, Brian Haugli, and CFO, Ryan Polk Reports have shown an increase in cyberattacks due to the growth in network attack surfaces for in-office and remote workers who rely on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business SideChannel’s newest product release, Enclave(TM), is a comprehensive cloud and network solution that enables IT teams to contain breaches faster, reduce network outages, minimize latency, and strengthen overall defensive security SideChannel (OTCQB: SDCH), a provider of cybersecurity services and technology, develops technologies…

Continue Reading

WednesdayJan 25, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs

Bioavailability measures the amount of a substance that enters the bloodstream, with most oral routes providing lower amounts of the drug due to poor bioavailability Studies on nutrients show that not all the nutrients we ingest actually enter the bloodstream due to inhibiting factors in the digestive tract Lexaria’s patented DehydraTECH(TM) technology helps increase bioavailability for active pharmaceutical ingredients (“APIs”), which has been shown through various animal and human clinical studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream…

Continue Reading

WednesdayJan 25, 2023 9:00 am

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Set to Potentially Benefit as Renowned Gold Bug, Claude Bejet, Says Now is the Time to Invest in Precious Metals

Claude Bejet, a long-time precious metals investor and author of the Swiss Gold Letter, was interviewed on the sidelines of the recent Mines and Money Conference in London During his interview, Bejet commented on his optimism in regards to the precious metals complex as well as the considerable value held by junior mining companies Eloro Resources possesses a 100% option agreement on the Iska Iska deposit, a major polymetallic epithermal porphyry complex covering over 900 hectares of land The company is due to publish their initial assessment of Iska iska’s resource potential by March 2023, a process which Eloro are…

Continue Reading

TuesdayJan 24, 2023 12:00 pm

9th Annual Podfest Expo(R) 2023 At Renaissance Orlando at SeaWorld(R) 

The Podfest Expo(R), being held at Renaissance Orlando at SeaWorld(R) on January 26-29, 2023, unites a community of international enthusiasts devoted to podcasting technology and general communication with the world through the medium of audio and video. Main stage sponsor SiriusXM will be represented at the 9th Annual Podfest Expo(R) 2023 supporting a community of creators whos’ origin began in 2013 as a meetup of 13 attendees. This year’s expo will be topping 1500+ Podcasters enjoying an immersive experience with over 200 Subject matter experts sharing their best practices  The venue of the event is Renaissance Orlando at SeaWorld(R) -…

Continue Reading

TuesdayJan 24, 2023 11:15 am

DGE’s Supplier Diversity & Economic Inclusion For Pharma & Healthcare

Supply chain professionals and executives in the health and pharma spectrum are invited to attend the premiere Supplier Diversity & Economic Inclusion for Pharma & Healthcare Summit, streaming online on March 7-8th, 2023. Gain important insights and actionable strategies for strengthening supply chains by committing towards diversity, equity, and inclusion. Supplier diversity is a relatively new term in supply chain management for pharma and healthcare. There is plenty of scope and need for market leaders who can streamline supplier diversity – including procurement, sourcing, regulatory, compliance, and other areas. Discover and overcome the most critical hurdles of working with small…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217